Department of Cardiovascular Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Cardiovascular Surgery, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Artif Organs. 2022 Apr;46(4):633-642. doi: 10.1111/aor.14102. Epub 2021 Nov 12.
We have previously applied in vivo tissue-engineered vascular grafts constructed in patients' subcutaneous spaces. However, since the formation of these vascular grafts depends on host health, their application is challenging in patients with suppressed regenerative ability. Therefore, the allogeneic implantation of grafts from healthy donors needs to be evaluated. This study aimed to fabricate allogeneic cardiovascular grafts in animals.
Silicone rod molds were implanted into subcutaneous pouches in dogs; the implants, along with surrounding connective tissues, were harvested after four weeks. Tubular connective tissues were decellularized and stored before they were cut open, trimmed to elliptical sheets, and implanted into the common carotid arteries of another dog as vascular patches (n = 6); these were resected and histologically evaluated at 1, 2, and 4 weeks after implantation.
No aneurysmal changes were observed by echocardiography. Histologically, we observed neointima formation on the luminal graft surface and graft wall cell infiltration. At 2 and 4 weeks after implantation, α-SMA-positive cells were observed in the neointima and graft wall. At 4 weeks after implantation, the endothelial lining was observed at the grafts' luminal surfaces.
Our data suggest that decellularized connective tissue membranes can be prepared and stored for later use as allogeneic cardiovascular grafts.
我们之前曾在患者的皮下空间中应用过体内组织工程血管移植物。然而,由于这些血管移植物的形成依赖于宿主的健康状况,因此在再生能力受到抑制的患者中应用具有挑战性。因此,需要评估来自健康供体的同种异体移植物的植入。本研究旨在在动物中构建同种异体心血管移植物。
将硅酮棒模具植入犬的皮下囊中;在四周后,取出包含植入物和周围结缔组织的移植物。将管状结缔组织去细胞化并储存,然后将其切开、修剪成椭圆形片,并植入另一只狗的颈总动脉作为血管补片(n=6);在植入后 1、2 和 4 周切除并进行组织学评估。
超声心动图未观察到动脉瘤样改变。组织学观察到管腔移植物表面和移植物壁细胞浸润形成的新生内膜。在植入后 2 和 4 周,观察到α-SMA 阳性细胞存在于新生内膜和移植物壁中。在植入后 4 周,观察到移植物管腔表面的内皮衬里。
我们的数据表明,可以制备和储存去细胞化的结缔组织膜,以备将来作为同种异体心血管移植物使用。